JPWO2020160342A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020160342A5 JPWO2020160342A5 JP2021544344A JP2021544344A JPWO2020160342A5 JP WO2020160342 A5 JPWO2020160342 A5 JP WO2020160342A5 JP 2021544344 A JP2021544344 A JP 2021544344A JP 2021544344 A JP2021544344 A JP 2021544344A JP WO2020160342 A5 JPWO2020160342 A5 JP WO2020160342A5
- Authority
- JP
- Japan
- Prior art keywords
- snp
- snps
- disease
- disorder
- alternatively
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024202674A JP2025037913A (ja) | 2019-01-30 | 2024-11-20 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798908P | 2019-01-30 | 2019-01-30 | |
| PCT/US2020/015982 WO2020160342A1 (en) | 2019-01-30 | 2020-01-30 | Methods and compositions for developing target specific exosome and growth factor products |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024202674A Division JP2025037913A (ja) | 2019-01-30 | 2024-11-20 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535178A JP2022535178A (ja) | 2022-08-05 |
| JPWO2020160342A5 true JPWO2020160342A5 (https=) | 2023-02-07 |
| JP2022535178A5 JP2022535178A5 (https=) | 2023-02-07 |
Family
ID=71842346
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544344A Pending JP2022535178A (ja) | 2019-01-30 | 2020-01-30 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
| JP2024202674A Pending JP2025037913A (ja) | 2019-01-30 | 2024-11-20 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024202674A Pending JP2025037913A (ja) | 2019-01-30 | 2024-11-20 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220136053A1 (https=) |
| EP (1) | EP3917489A4 (https=) |
| JP (2) | JP2022535178A (https=) |
| KR (1) | KR20210121183A (https=) |
| AU (1) | AU2020214832A1 (https=) |
| BR (1) | BR112021014994A2 (https=) |
| CA (1) | CA3128050A1 (https=) |
| IL (1) | IL285228A (https=) |
| JO (1) | JOP20210202A1 (https=) |
| MX (1) | MX2021009254A (https=) |
| SG (1) | SG11202108129SA (https=) |
| WO (1) | WO2020160342A1 (https=) |
| ZA (1) | ZA202105483B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021526556A (ja) | 2018-05-30 | 2021-10-07 | ダイレクト バイオロジクス エルエルシー | 成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞（ｍｓｃ）の調製物を含む助剤、ならびにその使用方法 |
| BR112021015549A2 (pt) | 2019-02-07 | 2021-10-26 | Direct Biologics Llc | Método para tratar osteoartrite com uma combinação de exossomos de células tronco mesenquimais, células tronco mesenquimais sinoviais e andaimes |
| CA3146433A1 (en) | 2019-07-18 | 2021-01-21 | Direct Biologics Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| US12590310B2 (en) | 2020-04-22 | 2026-03-31 | Direct Biologics, Llc | Methods and compositions for treating inflammatory conditions associated with infectious disease |
| JP2023180556A (ja) * | 2022-06-09 | 2023-12-21 | 日本メナード化粧品株式会社 | 薄毛の遺伝的素因の判定方法 |
| WO2024233684A2 (en) * | 2023-05-08 | 2024-11-14 | Vitti Labs | Methods of treating ovarian conditions and diseases |
| US12502407B2 (en) | 2024-04-25 | 2025-12-23 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
| CN118516305B (zh) * | 2024-07-22 | 2024-11-26 | 深圳大学 | 力学信号调控下的外泌体制备方法、外泌体及其在骨、软骨再生修复领域的应用 |
| CN120899659A (zh) * | 2025-08-06 | 2025-11-07 | 河北医科大学第三医院 | 一种过表达cap基因和lgr5基因的外泌体在制备治疗软骨炎症药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090177487A1 (en) * | 2008-01-07 | 2009-07-09 | Tera Eerkes | Methods for Assessing Genetic Compatibility |
| CN102014934B (zh) * | 2008-02-22 | 2014-08-20 | 新加坡科技研究局 | 间充质干细胞颗粒 |
| ES2746554T3 (es) * | 2010-11-02 | 2020-03-06 | Univ Columbia | Métodos para tratar los trastornos de pérdida de cabello |
| US20130129688A1 (en) * | 2011-11-09 | 2013-05-23 | Allocure, Inc. | Assay for the Prediction of Therapeutic Effectiveness or Potency of Mesenchymal Stem Cells, and Methods of Using Same |
| CA2866563A1 (en) * | 2012-03-07 | 2013-09-12 | Fibrocell Technologies, Inc. | Topical dermal formulations and methods of personalized treatment of skin |
| EP3270984A4 (en) * | 2015-03-16 | 2019-04-17 | Duncan Ross | TREATMENT METHOD WITH MEMBRANE-INCLUDED VESICLE |
| AU2016261358B2 (en) * | 2015-05-11 | 2021-09-16 | Editas Medicine, Inc. | Optimized CRISPR/Cas9 systems and methods for gene editing in stem cells |
| MX2019005127A (es) * | 2016-11-03 | 2019-09-26 | Exostem Biotec Ltd | Poblaciones y productos de células madre mesenquimales y sus usos. |
| US10987381B2 (en) * | 2017-01-27 | 2021-04-27 | Neil Riordan | Mesenchymal stem cells with enhanced efficacy in treatment of autoimmunity particularly rheumatoid arthritis |
| WO2018162696A1 (en) * | 2017-03-10 | 2018-09-13 | Institut Pasteur | Common genetic variations at the tcra-tcrd locus control thymic function in humans |
| JP2021526556A (ja) * | 2018-05-30 | 2021-10-07 | ダイレクト バイオロジクス エルエルシー | 成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞（ｍｓｃ）の調製物を含む助剤、ならびにその使用方法 |
| KR20210121039A (ko) * | 2018-12-26 | 2021-10-07 | 다이렉트 바이오로직스 엘엘씨 | 피부 및 모발 장애를 치료하기 위한 방법 및 조성물 |
-
2020
- 2020-01-30 AU AU2020214832A patent/AU2020214832A1/en not_active Abandoned
- 2020-01-30 SG SG11202108129SA patent/SG11202108129SA/en unknown
- 2020-01-30 WO PCT/US2020/015982 patent/WO2020160342A1/en not_active Ceased
- 2020-01-30 CA CA3128050A patent/CA3128050A1/en active Pending
- 2020-01-30 JP JP2021544344A patent/JP2022535178A/ja active Pending
- 2020-01-30 BR BR112021014994-5A patent/BR112021014994A2/pt not_active Application Discontinuation
- 2020-01-30 KR KR1020217027591A patent/KR20210121183A/ko not_active Withdrawn
- 2020-01-30 JO JOP/2021/0202A patent/JOP20210202A1/ar unknown
- 2020-01-30 MX MX2021009254A patent/MX2021009254A/es unknown
- 2020-01-30 EP EP20748749.7A patent/EP3917489A4/en active Pending
- 2020-01-30 US US17/427,192 patent/US20220136053A1/en active Pending
-
2021
- 2021-07-29 IL IL285228A patent/IL285228A/en unknown
- 2021-08-02 ZA ZA2021/05483A patent/ZA202105483B/en unknown
-
2024
- 2024-11-20 JP JP2024202674A patent/JP2025037913A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gimple et al. | Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer | |
| Yu et al. | N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability | |
| Madhyastha et al. | MicroRNA signature in diabetic wound healing: promotive role of miR‐21 in fibroblast migration | |
| CN102625853B (zh) | 表皮分化微小rna标记及其应用 | |
| Lacey et al. | Atherosclerosis-associated differentially methylated regions can reflect the disease phenotype and are often at enhancers | |
| EP4205750B1 (en) | Nadph oxidase inhibitor for suppressing or improving hair loss or treating alopecia | |
| Lee et al. | DNA methyltransferase inhibition accelerates the immunomodulation and migration of human mesenchymal stem cells | |
| Konicke et al. | The microRNA landscape of cutaneous squamous cell carcinoma | |
| JPWO2020160342A5 (https=) | ||
| JP2026053554A (ja) | ｍｉＲ－５２０ｄ－５ｐを利用したヘアサイクル関連遺伝子の修復方法及びヘアサイクル関連疾患の処置方法 | |
| Li et al. | Context-dependent T-BOX transcription factor family: from biology to targeted therapy | |
| Jiang et al. | miR-624 accelerates the growth of liver cancer cells by inhibiting EMC3 | |
| WO2012082821A2 (en) | Melanoma treatments | |
| CN116396963A (zh) | 一类抑制血管内皮生长因子a表达的三链形成寡核苷酸及其应用 | |
| CN108977443B (zh) | 一种表达动脉粥样硬化炎症活动的环状rna及其应用 | |
| Navarro et al. | An indirect role for the oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells | |
| Tanaka et al. | Huaier Induces Cancer Recovery by Rescuing Impaired Function of Transcription Control Based on the Individual Genomic Potential | |
| CN101418293A (zh) | 微小rna-21的反义寡聚核苷酸及其应用 | |
| EP3903793A1 (en) | Pharmaceutical composition comprising clonal stem cell for prevention or treatment of atopic dermatitis | |
| Siegrist et al. | MicroRNA expression profiling by bead array technology in human tumor cell lines treated with interferon-alpha-2a | |
| RU2021122946A (ru) | Способы и композиции для разработки целевых специфических продуктов экзосом и факторов роста | |
| CN103948926A (zh) | miR-9抑制剂在制备用于抑制肿瘤生长药物中的用途 | |
| JP2024028895A (ja) | オリゴヌクレオチド分子及び腫瘍治療におけるその応用 | |
| Yilmaz et al. | Prospects of integrated multi-omics-driven biomarkers for efficient hair loss therapy from systems biology perspective | |
| Jin et al. | Circular RNA 001569 acts as an oncogene and correlates with aggressive characteristics in hepatocellular carcinoma |